Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NGN Capital LLC is a venture capital firm established to concentrate on healthcare investing. Founded in New York, NY, the firm also operates an office in Heidelberg, Germany. NGN Capital specializes in later-stage investments within the healthcare and biotechnology sectors, targeting areas such as drug products, medical devices, and healthcare services. The firm predominantly invests in the United States and Europe, aligning its strategy with the growing demand for innovative healthcare solutions.
Currently, NGN Capital manages two primary funds: NGN BioMed Opportunity I and NGN BioMed Opportunity II. These funds reflect the firm’s commitment to achieving above-average private equity returns through a diversified investment strategy. The firm has built a reputation for its focus on later-stage opportunities while remaining open to selected early-stage investments, allowing it to adapt to the evolving healthcare landscape.
NGN Capital invests across a broad spectrum of healthcare and biotechnology segments, with a strong emphasis on later-stage opportunities. The firm’s investment strategy is designed to achieve above-average private equity returns through diversification. This includes a focus on drug products, medical devices, and healthcare services, which are critical areas in the healthcare sector.
While the firm primarily targets later-stage investments, it also considers selected early-stage opportunities that align with its strategic goals. This dual approach allows NGN Capital to capitalize on emerging trends in healthcare while supporting companies that are already established in the market. The firm’s geographical focus spans North America and Europe, providing a wide range of investment opportunities in these regions.
NGN Capital manages two primary funds: NGN BioMed Opportunity I and NGN BioMed Opportunity II. While specific portfolio companies or case studies were not detailed in the provided content, the firm’s focus on later-stage healthcare and biotechnology investments suggests a diverse range of companies within its portfolio. The emphasis on drug products, medical devices, and healthcare services indicates that the firm likely supports companies that are innovating in these critical areas of healthcare.
Investors and founders interested in NGN Capital should note that the firm’s strategy is aligned with the growing demand for advancements in healthcare technology and services. This positions NGN Capital as a significant player in the healthcare investment space, particularly for companies looking to scale and expand their market presence.
Kenneth S. Abramowitz, Managing General Partner, has extensive experience in healthcare investments and has led numerous successful deals in the sector.
John R. Costantino, Managing General Partner, brings a wealth of knowledge in venture capital and has a strong track record in healthcare and biotechnology.
Peter Johann, Managing General Partner, specializes in later-stage investments and has a deep understanding of the healthcare market.
Alexander Cuomo, Chief Financial Officer, oversees financial operations and fund management, ensuring the firm's financial health.
William J. Gedale, Senior Advisor, provides strategic insights and guidance based on his extensive experience in the industry.
Kenneth J. Gorelick, Venture Partner, contributes his expertise in venture capital and healthcare investments, enhancing the firm's strategic direction.
To pitch NGN Capital, founders should visit the firm's website and submit their proposals through the designated channel. A well-structured pitch deck should include key information about the business, market opportunity, and financial forecasts.
What are NGN Capital's investment criteria?
NGN Capital focuses on later-stage investments in healthcare and biotechnology, including drug products, medical devices, and healthcare services. The firm also considers selected early-stage investments that align with its strategic goals.
How can I pitch to NGN Capital?
Founders can submit their pitches through NGN Capital's website. It is advisable to include a comprehensive overview of the business model, market opportunity, and financial projections in the pitch deck.
What makes NGN Capital different from other VC firms?
NGN Capital specializes in healthcare and biotechnology, emphasizing later-stage investments. This focus allows the firm to leverage its expertise and network to support portfolio companies effectively.
What is the geographic scope of NGN Capital's investments?
The firm predominantly invests in North America and Europe, providing a broad range of opportunities in these regions.
What kind of support can portfolio companies expect?
NGN Capital provides operational support, strategic guidance, and access to a network of industry contacts to help portfolio companies grow and succeed in their respective markets.
What is the typical check size for investments?
While specific check sizes were not disclosed, NGN Capital focuses on later-stage investments, which typically involve larger capital commitments compared to early-stage funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.